$4.07
-0.17-4.01%
In chiusura: -
$4.12
0.051.23%
After hour: 6:15 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Vistagen Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 18
Stima EPS
$-0.470
Stima dei ricavi trimestrali
$339.48K
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$646.00K
Analizza lo storico degli utili di Vistagen Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
VTGN | VistaGen Therapeutics | -$0.42 | -$0.47 | — | — | $183.00K | $339.48K | — | — | 11/18/2025 | |
VTGN | VistaGen Therapeutics | -$0.35 | -$0.45 | -$0.47 | -4.44% | $84.00K | $389.40K | $244.00K | -37.34% | 08/07/2025 | |
VTGN | VistaGen Therapeutics | -$0.25 | -$0.49 | -$0.44 | 10.20% | $197.30K | $209.33K | -$15.00K | -107.17% | 06/17/2025 | |
VTGN | VistaGen Therapeutics | -$0.22 | -$0.52 | -$0.46 | 11.54% | $411.40K | $179.25K | $234.00K | 30.54% | 02/13/2025 | |
VTGN | VistaGen Therapeutics | -$0.66 | -$0.39 | -$0.42 | -7.69% | $277.70K | $220.00K | $183.00K | -16.82% | 11/07/2024 | |
VTGN | VistaGen Therapeutics | -$0.94 | -$0.40 | -$0.35 | 12.50% | $177.60K | $300.00K | $84.00K | -72.00% | 08/13/2024 | |
VTGN | VistaGen Therapeutics | -$1.61 | -$0.37 | -$0.25 | 32.43% | $175.60K | $410.00K | $197.30K | -51.88% | 06/11/2024 | |
VTGN | VistaGen Therapeutics | -$1.42 | -$0.30 | -$0.22 | 26.67% | $179.60K | $540.00K | $411.40K | -23.81% | 02/13/2024 | |
VTGN | VistaGen Therapeutics | -$2.40 | -$0.68 | -$0.66 | 2.94% | -$892.50K | $180.00K | $277.70K | 54.28% | 11/09/2023 | |
VTGN | VistaGen Therapeutics | -$3.00 | — | -$0.94 | — | $310.10K | — | $177.60K | — | 08/10/2023 | |
VTGN | VistaGen Therapeutics | -$2.70 | — | -$1.61 | — | $38.90K | — | $175.60K | — | 06/28/2023 | |
VTGN | VistaGen Therapeutics | -$1.50 | -$2.10 | -$1.50 | 28.57% | $357.90K | $150.00K | $179.60K | 19.73% | 02/07/2023 | |
VTGN | VistaGen Therapeutics | -$2.10 | -$2.10 | -$2.40 | -14.29% | $358.00K | $310.00K | -$892.50K | -387.90% | 11/10/2022 | |
VTGN | VistaGen Therapeutics | -$1.20 | -$2.10 | -$3.00 | -42.86% | $354.10K | — | $310.10K | — | 08/11/2022 | |
VTGN | VistaGen Therapeutics | -$9.00 | -$1.80 | -$2.70 | -50.00% | $441.90K | $350.00K | $38.90K | -88.89% | 06/23/2022 | |
VTGN | VistaGen Therapeutics | -$2.10 | -$2.10 | -$1.50 | 28.57% | $313.60K | $250.00K | $357.90K | 43.16% | 02/10/2022 | |
VTGN | VistaGen Therapeutics | -$1.50 | -$1.80 | -$2.10 | -16.67% | $334.00K | $260.00K | $358.00K | 37.69% | 11/10/2021 | |
VTGN | VistaGen Therapeutics | -$2.10 | -$1.50 | -$1.20 | 20.00% | $0.00 | $380.00K | $354.10K | -6.82% | 08/12/2021 | |
VTGN | VistaGen Therapeutics | -$2.10 | -$1.50 | -$9.00 | -500.00% | $0.00 | $230.00K | $441.90K | 92.13% | 06/29/2021 | |
VTGN | VistaGen Therapeutics | -$4.50 | -$1.50 | -$2.10 | -40.00% | $0.00 | $210.00K | $313.60K | 49.33% | 02/11/2021 | |
VTGN | VistaGen Therapeutics | -$3.90 | -$0.60 | -$1.50 | -150.00% | $0.00 | $1.67M | $334.00K | -80.00% | 11/12/2020 |
Vistagen Therapeutics (VTGN) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q1 | 2025-08-07 | $-0.47 | $-0.45 | -4.44 % |
| Q4 | 2025-06-17 | $-0.44 | $-0.49 | 10.2 % |
| Q3 | 2025-02-13 | $-0.46 | $-0.52 | 11.5 % |
| Q2 | 2024-11-07 | $-0.42 | $-0.39 | -7.69 % |
Vistagen Therapeutics (VTGN) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q1 | 2025-08-07 | $244.00K | $389.40K | -37.3 % |
| Q4 | 2025-06-17 | $-15.00K | $209.33K | -107.2 % |
| Q3 | 2025-02-13 | $234.00K | $179.25K | 30.5 % |
| Q2 | 2024-11-07 | $183.00K | $220.00K | -16.8 % |
FAQ
Quando Vistagen Therapeutics (NASDAQ:VTGN) riporterà gli utili?
Si prevede che Vistagen Therapeutics (VTGN) fornisca risultati il novembre 18, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q1.
Quali sono stati gli ultimi utili per azione (EPS) di Vistagen Therapeutics (NASDAQ:VTGN)?
L'EPS effettivo era $-0.47, che mancato la stima di $-0.45.
Quali sono state le entrate di Vistagen Therapeutics (NASDAQ:VTGN)?
Le entrate effettive sono state $244K, che mancato la stima di $389.4K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.